Detalles de la búsqueda
1.
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping.
Ann Oncol
; 30(2): 290-296, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30535340
2.
Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study.
Ann Oncol
; 29(10): 2076-2084, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30137193
3.
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial.
ESMO Open
; 8(3): 101576, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285717
4.
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer.
J Immunother Cancer
; 10(8)2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36002182
5.
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis.
Cancer Treat Res Commun
; 27: 100378, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905962
6.
Analysis of mismatch repair (MMR) proteins expression in a series of malignant pleural mesothelioma (MPM) patients.
Clin Transl Oncol
; 22(8): 1390-1398, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31916017
7.
From N-of-one to series of exceptional responders: unlocking the mystery of outliers in oncology.
ESMO Open
; 8(5): 101833, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37769399
8.
Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).
Lung Cancer
; 96: 1-6, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27133741
Resultados
1 -
8
de 8
1
Próxima >
>>